MOMP telonanoparticles, and related compositions, methods and systems
US11207422B2 · kind B2 · utility
5Cited by
29References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 2018 |
| Grant date | Dec 28, 2021 |
| Priority date | — |
| Expiry date | May 1, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/6093
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A telodendrimer-nanolipoprotein particle (t-NLP), comprising one or more membrane forming lipids, one or more telodendrimers, and a scaffold protein and a Chlamydia major outer membrane protein (MOMP) comprising a MOMP hydrophobic region, and related compositions methods and systems.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.